 "Ajanta Pharma")
Ajanta Pharma on Tuesday said its consolidated profit after tax (PAT) increased 18 per cent year-on-year to Rs 246 crore for the June quarter, on account of robust sales across domestic and international markets.
The drug firm had reported a profit after tax of Rs 208 crore in the April-June quarter of last fiscal.
Revenue from operations rose to Rs 1,145 crore during the quarter under review as against Rs 1,021 crore in the year-go period, Ajanta Pharma said in a regulatory filing.
The company said its India sales grew 10 per cent year-on-year to Rs 353 crore in the first quarter.
The company's US sales grew 7 per cent to Rs 228 crore in the first quarter of the current fiscal.
Shares of Ajanta Pharma ended 3.99 per cent up at Rs 2,524.35 apiece on the BSE.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
 "Photo: Bloomberg")
 "pharma, medicine, drugs")
 "Sugar, Sugar crop")
 "India at Paris Olympics 2024: India match live updates on July 30")
 "(From left) 10m Air Pistol Mixed Silver medallists Sevval Ilayda Tarhan, Yusuf Dikec of Turkey; Gold medallists Zorana Arunovic, Damir Mikec of Serbia, and Bronze medallists Manu Bhaker, Sarabjot Singh of India pose for a selfie | Photo: reuters")
